EXTON, Pa.--(BUSINESS WIRE)--Absorption Systems, LP, today announced that results of a recent investigation of interactions between drugs using Absorption Systems’ CellPort Technologies™ were presented by AstraZeneca at the International Society for the Study of Xenobiotics (ISSX) Meeting, which was held recently in San Diego. The results demonstrate that CellPort Technologies can help predict the potential for pharmacokinetic drug-drug interactions by examining the activity of specific transport proteins involved in the transport of drug molecules across cell membranes.
